Detalles de la búsqueda
1.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 51(2): 558-567, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37736808
2.
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Lancet Oncol
; 24(3): e121-e132, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36858728
3.
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Eur J Nucl Med Mol Imaging
; 50(8): 2529-2536, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905411
4.
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.
BJU Int
; 127(6): 703-711, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33113260
5.
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy.
Eur J Nucl Med Mol Imaging
; 47(10): 2328-2338, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32179961
6.
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
BMC Cancer
; 20(1): 362, 2020 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32349700
7.
Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy.
Pediatr Blood Cancer
; 67(12): e28664, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32881313
8.
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction.
Eur J Nucl Med Mol Imaging
; 46(4): 889-900, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30488099
9.
Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer.
World J Urol
; 37(3): 457-467, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30030659
10.
The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma.
World J Urol
; 33(6): 881-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25179013
11.
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy.
Radiother Oncol
; 194: 110215, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458259
12.
Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
Front Oncol
; 13: 1268309, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37799463
13.
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer.
JAMA Netw Open
; 6(5): e2314748, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37219907
14.
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Radiother Oncol
; 184: 109678, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146766
15.
Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
J Urol
; 187(1): 289-95, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22099991
16.
Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model.
J Urol
; 188(2): 607-14, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22704448
17.
Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes.
BJU Int
; 110(11): 1595-601, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22540956
18.
Impact of comorbidity on complications after nephrectomy: use of the Clavien Classification of Surgical Complications.
BJU Int
; 110(5): 682-7, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22432906
19.
Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model.
BJU Int
; 110(6 Pt B): E281-6, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22612555
20.
Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study.
Radiother Oncol
; 168: 256-264, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101466